Japan AED Makers See At Least 13 Percent Sales Decline This Fiscal Year
This article was originally published in PharmAsia News
Executive Summary
Two Japan-based medical-device makers see reduced sales of automated external defibrillators holding down operating profits for the fiscal year that began in April. Nihon Kohden forecasts a fall of 13 percent in AED sales, including in the United States and other countries where cost-cutting is under way. Fukuda Denshi expects a bigger drop in AED sales, by 16 percent. (Click here for more - a subscription may be required
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.